This webinar will be hosted live and available on-demand

Thursday, September 21, 2023 
11:30 AM Eastern Time 

Vaccines offer scientists and clinicians the ability to enhance or modulate the immune system, which carries unique promise for cancer treatment. Whether targeting the inherent tumor-killing abilities of immune cells or improving efficacy of established immunotherapies, researchers work towards therapeutic vaccines that boost the anticancer immune system.

In this webinar brought to you by The Scientist, Denise Cecil and James Gulley will share new progress in the cancer vaccine field. They will highlight the scientific rationale behind these preventatives, explain which cancers are the primary targets, and discuss the main obstacles to cancer vaccine implementation.

Topics to be covered 

  • The role that therapeutic vaccines play when paired with immunotherapy 
  • The latest clinical trial data on therapeutic vaccines for multiple forms of cancer
Denise

Denise Cecil, PhD 
Principal Scientist
Cancer Vaccine Institute
University of Washington

James L. Gulley, MD, PhD

James L. Gulley, MD, PhD 
Senior Investigator
Co-Director, Center for Immuno-Oncology
Deputy Director, Center for Cancer Research 
Clinical Director, National Cancer Institute



Sponsored by